SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mawson Infrastructure Group, Inc. engages in the provision of digital asset infrastructure services. The company was founded on February 10, 2012 and is headquartered in Midland, PA.

Mawson Infrastructure Group Inc

MIGI is trending due to a combination of factors including its shift to a hybrid infrastructure model with AI GPU hosting, potential short squeeze, and positive sentiment from an ongoing conference. Community members are closely watching for a breakout above key resistance levels, while also acknowledging the risks associated with volatility and dilution. The stock's low float is contributing to significant price swings.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending as investors anticipate earnings, with much of the conversation centered on its potential role in the AI landscape and possible new deals with major tech players like Microsoft. Community members are weighing the potential for a significant post-earnings move, drawing comparisons to both positive and negative reactions from other tech companies like Oracle. Bullish sentiment seems to be fueled by expectations of strong AI revenue growth and the company's existing relationships with Google and Meta.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is surging amid excitement surrounding its affiliate Gemini Titan securing a CFTC license for regulated prediction markets, potentially positioning the company to compete with platforms like Kalshi and Polymarket. Community members are actively discussing the potential for a short squeeze, speculating on price targets and a possible return to IPO levels. Bullish sentiment is fueled by optimism surrounding the new market opportunities and the view that the license significantly undervalues the stock.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is experiencing volatility, driven by recent data showing a slowdown in November trading volumes and a price target adjustment from analysts. The community is actively debating whether the dip presents a buying opportunity or signals further declines, while also discussing the potential impact of Robinhood's expansion into prediction markets and banking services. Some traders express frustration with the stock's price action, citing manipulation and correlation with Bitcoin's movements.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending due to upcoming earnings, with the community actively debating whether the report will catalyze a significant price movement. Some traders are pointing to large options positions as a sign of an impending surge, while others remain cautious, citing broader economic concerns and potential tariff impacts. Bullish investors highlight Lululemon's brand strength, international growth potential, and compelling valuation, while bears express concerns about competition and declining sales.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending ahead of its Autonomy and AI Day, where the company is expected to showcase its in-house software and self-driving technology; community chatter revolves around speculation on potential announcements and comparisons to Tesla's approach, particularly regarding lidar; broader discussion includes debate around Rivian's valuation, production capabilities, and long-term strategy in the competitive EV market.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending down as investors react to concerns over increased spending on AI infrastructure and growing debt, despite a solid backlog. The community is debating whether the drop is an overreaction or a sign of deeper issues, while analysts are trimming their price targets. Some traders are looking for a bottom while others are anticipating a further decline.

AXIL Brands, Inc. engages in the manufacture, market, sale and distribution of hearing and audio enhancement, and protection products. It operates through the Hearing Enhancement and Protection, and Hair Care and Skin Care segments. The Hearing Enhancement and Protection segment includes ear buds, earmuffs, ear plugs, outdoor speakers, and ear care items. The Hair Care and Skin Care segment focuses on expanding its business-to-business salon sales through its network of domestic and international distributors. The company was founded on May 21, 2015 and is headquartered in Beverly Hills, CA.

AXIL Brands Inc.

AXIL Brands is trending due to a recently announced national retail distribution agreement with Walmart, which is expected to bring its hearing protection products to a wider audience. The community is actively discussing potential short squeezes and debating whether the Walmart news justifies the stock's increased price, while some express concern about potential pullbacks. Analysts' target prices also seem to be fueling conversation around the stock.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

The Trade Desk is trending as investors debate whether the recent price drop represents a buying opportunity or signals deeper problems, with discussions around potential tax-loss harvesting, analyst target price downgrades, and the company's competitive position against larger players like Amazon. Community members are actively discussing the possibility of a CEO change, potential acquisitions, and the impact of institutional buying versus retail sentiment.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

VELO is trending as investors discuss its deepening ties with major defense and aerospace companies, sparking optimism about future contracts and revenue growth. The community is highlighting the company's unique 3D printing capabilities for complex parts and its potential to disrupt traditional manufacturing. Some investors are pointing to a possible short squeeze and comparing the stock's potential to that of $SMX.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akebia Therapeutics, Inc. (NASDAQ:AKBA) Receives Consensus Rating of "Moderate Buy" from Analysts

Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA - Get Free Report) have been assigned an average rating of "Moderate Buy" from the eight research firms that are presently covering the company...

<ul class="summary-bullets"><li>ADX-097 is designed to inhibit complement activation, an integral part of the innate immune system, and has potential across kidney, autoimmune, vascular and skin diseases.</li><li>Q32 Bio is also eligible to receive tiered royalties on potential future sales of ADX-097, ranging from low single-digit to mid-teen percentages.</li><li>The company is now focussed on advancing Bempikibart for patients with alopecia areata.</li></ul> Shares of Q32 Bio Inc. (QTTB) jumped 98% on Monday after the company sold its experimental drug ADX-097, to Akebia Therapeutics, Inc. (AKBA) for up to $592 million.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.q32bio.com/news-releases/news-release-details/q32-bio-sells-complement-inhibitor-adx-097">said</a> that the sale extends its cash runway into the second half of 2027. ADX-097 is designed to inhibit complement activation, an integral part of the innate immune system, and has potential across kidney, autoimmune, vascular and skin diseases.<h2 class="st-heading-2">Terms Of The Deal</h2>Akebia will now be responsible for future development and commercialization of ADX-097. Under the deal, Q32 Bio will receive $12 million in upfront payments and near-term milestone payments.These payments as well as potential development, regulatory and commercial milestones total up to $592 million, the company said. Q32 Bio is also eligible to receive tiered royalties on potential future sales of ADX-097, ranging from low single-digit to mid-teen percentages.ADX-097 is the lead product candidate from Q32 Bio's tissue-targeted complement inhibitor platform. Q32 Bio, however, retains the rights to the platform, including ADX-096 being developed for ophthalmologic indications and other remaining early-stage assets and is continuing to evaluate strategic options for these programs.The company is now focussed on advancing Bempikibart for patients with alopecia areata, an autoimmune disorder that causes the immune system to attack hair follicles, resulting in sudden, patchy hair loss, most commonly on the scalp.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/QTTB">QTTB stock</a> stayed within the ‘neutral’ territory over the past 24 hours, while message volume stayed at ‘low’ levels.<figure class="image"><img style="aspect-ratio:586/57;" src="data:image/png;base64,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" alt="QTTB’s Sentiment Meter and Message Volume as of 12:40 p.m. ET on Nov. 28, 2025 | Source: Stocktwits" width="586" height="57"><figcaption>QTTB’s Sentiment Meter and Message Volume as of 12:40 p.m. ET on Dec. 1, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user sees the deal opening opportunities for the company.<stembedurl>https://stocktwits.com/topstockalerts/message/637812919</stembedurl>QTTB stock is up by 26% this year but down by about 84% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/connecticut-attorney-general-presses-bnpl-firms-paypal-sezzle-on-fees-disclosure-debt-risks/cLI71TxREiD">Connecticut Attorney General Presses BNPL Firms PayPal, Sezzle On Fees, Disclosures And Debt Risks</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Q32 Bio Stock Soars On Selling Experimental Drug To Akeba For Up To $592M

The company said that the sale extends its cash runway into the second half of 2027.

Equity

The company said that the sale extends its cash runway into the second half of 2027.


Q32 Bio Sells Complement Inhibitor ADX-097

Q32 Bio Sells Complement Inhibitor ADX-097 Q32 Bio Sells Complement Inhibitor ADX-097 PR Newswire WALTHAM, Mass., Dec. 1, 2025 -- Asset sale further enables Company's strategic focus on advancing...

Akebia Therapeutics (NASDAQ:AKBA) Downgraded by Wall Street Zen to "Buy"

Wall Street Zen lowered Akebia Therapeutics from a "strong-buy" rating to a "buy" rating in a research note on Friday...

Q2 Earnings Forecast for AKBA Issued By HC Wainwright

Akebia Therapeutics, Inc. (NASDAQ:AKBA - Free Report) - Equities researchers at HC Wainwright issued their Q2 2026 EPS estimates for shares of Akebia Therapeutics in a research note issued to...

Implied Volatility Surging for Akebia Therapeutics Stock Options

Investors need to pay close attention to AKBA stock based on the movements in the options market lately.

Analysts Offer Predictions for AKBA Q1 Earnings

Akebia Therapeutics, Inc. (NASDAQ:AKBA - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Akebia Therapeutics in a research note issued...

Theravance's Q3 Earnings Surpass Estimates, Revenues Match

TBPH delivers a third-quarter profit, beating estimates, and 19% revenue growth, fueled by rising collaboration income from Viatris related to Yupelri sales.

Akebia Therapeutics (AKBA) Loses 39.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Akebia Therapeutics (AKBA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Mettler-Toledo Q3 Earnings Top Estimates, Sales Decline Y/Y

MTD posted stronger-than-expected Q3 results, lifted by segment growth and solid guidance for 2025 and 2026.


Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vafseo. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

Akebia Therapeutics Inc.

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

Current Price	$1.67
Prev Close	$1.63
Open	$1.64
Dividend Yield	0.00%
50-Day Moving Average	$2.22
Beta	1.47
Avg. Volume	5.11M
PE Ratio	-21.42

52-Week High	$4.08
52-Week Low	$1.45
Market Capitalization	$432.55M
EPS (Annual)	-$0.329
Price to Book	10.39
Revenue Per Employee	$884,972.38
Enterprise Value/EBITDA	N/A

AKBA
Akebia Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AKBA News

AKBAAkebia Therapeutics Inc.